Abstract OP0114 Table 1

	Treatment Group Control [n]	Treatment group RIS 2.5 mg [n]	Treatment Group RIS 5 mg [n]

Lumbar Spine (Prevention Study)	-3.4 (0.8)^* [19]	0.3 (1.3) [9]	0.8 (0.6)^ [24]
Femoral Neck (Prevention Study)	-3.3 (1.1)^* [20]	-0.7 (1.7) [9]	1.5 (1.0)^ [24]
Trochanter (Prevention Study)	-3.4 (0.9)^* [20]	-0.3 (1.1) [9]	1.5 (0.8)^ [24]
Lumbar Spine (Treatment Study)	1.2 (0.8) [22]	2.1 (0.8)^* [25]	4.8 (0.9)^*^ [25]
Femoral Neck (Treatment Study)	-0.2 (1.0) [24]	-0.7 (0.8) [25]	2.1 (0.7)^* [25]
Trochanter (Treatment Study)	0.5 (1.4) [24]	0.4 (0.8) [25]	2.6 (0.5)^* [25]

↵* p less than or equal to 0.05 vs. baseline; ^p less than or equal to 0.05 vs. control.